EM Review: Risk Rally Eased on Stimulus Delays, Vaccine Hitches
- China raised $6 billion from bonds sold on overseas markets
- Indonesia, S. Korea, Hungary, Chile kept policy rates on hold
This article is for subscribers only.
The October rally in emerging-market stocks slowed last week as delays to a U.S. fiscal stimulus package and setbacks in Covid-19 vaccine trials reduced risk appetite. A warning from the International Monetary Fund that the world economy still faces an uneven recovery added to the somber mood.
The following is a roundup of emerging-market news and highlights for the week through Oct. 18: